Divide $400m worth of vials by 700m shares You can use a calculator. Is that... "Greater than" or "Less than" $1.50?
Yeah, it's called "valuation" and "fundamental analysis"... When you say something is "underpriced" or "way undervalued," there's metrics for that. One is the actual value of the company, it's assets, etc. Current PPS is actually multiples *over* that.
At this point the value of the vials is near $0 dollars because there is no approval and only small amounts are being sold in the Philippines. The only real assets are the patents and potential FDA exclusivity. Until trials prove their worth they are of uncertain value. Trials like the one down in Brazil.